The Challenges facing the Global Pharmaceutical Industry

The Challenges facing the Global Pharmaceutical Industry


The global pharmaceutical industry is facing a challenging battle to maintain its productivity in the face of an increasingly difficult research and development landscape.


Companies are starting to commit fewer resources to research activities in recent years, partly due to diminishing returns.


Between 2007 and 2009, the number of treatments whose clinical development was terminated during phase III testing was double the rate seen in 2004-06, while fewer than one in ten drugs reaching first toxicity dose now make it market.

http://blogs.veedacr.com/Lists/Posts/Post.aspx?ID=324

No of Drugs by Development status


Watch out for some key statistics of the Pharma drug pipeline at-

http://blogs.veedacr.com/Lists/Posts/Post.aspx?ID=326